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We investigated the activity of curcumin against Proteus mirabilis and the struvite crystallization in relation to urinary stones
formation. In order to evaluate an activity of curcumin we performed an in vitro experiment of struvite growth from artiﬁcial
urine. The crystallization process was induced by Proteus mirabilis to mimic the real urinary tract infection, which usually leads to
urinary stone formation. The results demonstrate that curcumin exhibits the eﬀect against Proteus mirabilis inhibiting the activity
of urease—an enzyme produced by these microorganisms. Addition of curcumin increases the induction time and decreases the
eﬃciency of growth of struvite compared with the absence of curcumin. Interestingly, the addition of curcumin does not aﬀect the
crystal morphology and habit. In conclusion, curcumin has demonstrated its signiﬁcant potential to be further investigated for its
use in the case of struvite crystallization induced for the growth by Proteus mirabilis in relation to urinary stone formation.
1.Introduction
A large number of people (up to 20% of the pop-
ulation worldwide) are suﬀering from urinary stone
problem [1]. The majority of stones are composed of
oxalates, calcium salts, and phosphates. Among phosphates,
magnesium ammonium phosphate hexahydrate (MAPH;
MgNH4PO4·6H2O), known as struvite, is the predominant
crystalline component. Struvite crystallization is related
to urinary tract infections by microorganisms producing
urease. They are mainly the microorganisms from species
of Proteus, which are isolated in the case of 70% of
the so-called infectious stones [2, 3]. Urine of a healthy
person is undersaturated with regard to struvite forma-
tion. However, struvite stones are formed in the case of
urinary tract infection by urease-producing bacteria. This
happens because urease—bacterially produced enzyme—
splits urea, (NH2)2CO—natural component of urine—into
ammonia, NH3, and carbon dioxide, CO2, according to the
following reaction [4]:
(NH2)2CO
urease + H2O
−−−−−−−→ CO2 +2NH 3 (1)
ThisinturnraisesthepHoftheurine.IncreasingurinarypH
leadstotheelevationoftheconcentrationofNH+
4,CO 2−
3 and
PO3−
4 ions. These ions together with the ions of magnesium
Mg2+ present in the urine lead to the crystallization of
struvite, according to the following reaction [5]:
Mg2+ +NH +
4 +PO 3−
4 +6 H 2O
pH≥7.2
− −−−− → MgNH4PO4 ·6H2O
(2)
The precipitation of struvite occurs for pH≥7.2. The value
of pH is strongly correlated with supersaturation [6].
Struvite formation is usually associated with carbon-
ate apatite, Ca10(PO4)6CO3, precipitation because ions of
calcium Ca2+ are present in urine. The precipitation of
carbonate apatite runs according to the following reaction
[5]:
CO2−
3 +10Ca2+ +6 PO 3−
4
pH≥6.8
− −−−→ Ca10(PO4)6CO3 (3)
This component does not form crystals of deﬁned morphol-
ogy typical to struvite, it forms an amorphous precipitate.
Struvite together with small amount of carbonate apatite
(CA) forms the so-called infectious or struvite stones, which2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: The conﬁguration of keto form (a) and the most
energetically stable enol form (b) of curcumin.
are related to urinary tract infection. Struvite stone may
grow very rapidly and may involve the entire renal pelvis
and calyces, which may lead to the blockage of the urinary
tract and other serious medical problems including losing
a kidney [7, 8]. Therefore, a number of various drugs have
beendevelopedtocontrolthisdisease.Currently,along-term
antibiotictreatmentisadvisedinthecaseofinfectiousstones
[9]. Such a treatment should prevent also the recurrence
and regrowth of stone after treatment. However, long-
term systematic antibiotic therapy may be associated with
development of many adverse eﬀects such as gastrointestinal
problems or the emergence of bacterial resistance. Therefore,
several phytotherapeutic compounds have recently been
investigated to treat or prevent bacterial infections which
may lead to urinary stones [10, 11]. We focus our attention
on curcumin.
Curcumin (diferuloylmethane, chemical formula:
C21H20O6) is a yellow-orange pigment extracted from the
roots of turmeric (Curcuma longa). It usually exists in two
tautomeric forms: keto and enol–both these forms are
presented in Figure 1. The enol form is more energetically
stable [12]. Curcumin has attracted attention because of
its various biological activities [13]. Modern interest in
turmeric began in 1970s when it was found that turmeric
possesses antiinﬂammatory properties [14]. The signiﬁcance
of turmeric in medicine has changed since the antioxidant
properties of curcumin were discovered [15, 16]. Therefore,
curcumin is widely studied and it is found that curcumin
possesses also antitumour [17, 18], antibacterial [19, 20],
antifungal [21, 22]a n da n t i v i r a l[ 23, 24] properties. These
studies suggest that curcumin is a potent agent, which may
be applied in various pharmacological areas. Additionally,
curcumin does not exhibit toxicity to either animal or
humans even at high doses. Pharmacologically curcumin is
safe even at a dose of 8–10g/day [25–27].
In a previous paper [28]w eh a v er e p o r t e dt h ec h a r a c t e r -
ization of the structure of struvite crystals and some results
ontheeﬀectofcurcuminonitsbiomineralizationinartiﬁcial
urine. In the present study, we evaluate the properties
associated with curcumin with a view to extend the use of
curcumin in the case of struvite crystallization induced by
Proteus mirabilis in relation to urinary stone formation. For
this purpose, we performed in vitro experiments of struvite
crystalsmineralizationfromartiﬁcialurineinthepresenceof
P. mirabilis.Toourbestknowledge,ourstudyistheﬁrststudy
aiming to evaluate the activity of curcumin in the course of
urinary stone formation.
2.MaterialsandMethods
Curcumin (C21H20O6, CAS number: 458-37-7) was pur-
chased from Sigma and is a polyphenolic compound
extracted from Curcuma longa which belongs to Zingiber-
aceae family.
Proteus mirabilis strain was isolated from human kidney
stone. Before the crystal growth experiment, bacteria were
maintained on a slant of tryptic soy agar overnight at 37◦C
and then suspended in artiﬁcial urine with or without
curcumin to the concentration of 5 ×105 CFU per mL.
The artiﬁcial urine used during crystal growth exper-
iments was made from the following components [29]
(g/L): CaCl2·2H2O, 0.651; MgCl2·6H2O, 0.651; NaCl,4.6;
Na2SO4,2 . 3 ;K H 2PO4, 2.8; KCl, 1.6; NH4Cl, 1.0; urea, 25.0;
creatine, 1.1; tryptic soy broth (TSB), 10.0. The content of
the mineral components in such artiﬁcial urine corresponds
to mean concentration found in 24-hour period in normal
human urine. The crystallization occurs after addition of
the suspension of bacteria and incubation at 37◦C. The
crystallization process occurred at conditions emulating
the natural conditions existing at human body during the
infection by Proteus sp. During all the growth experiments,
crystal samples were taken at regular intervals and observed
by phase-contrast microscopy (Nikon Eclipse TE2000-S).
The pH of the solution of artiﬁcial urine was screened
alongtheexperimentsusingdigitalpH-meter(ElmetronCP-
215). Using this equipment the pH measurements are done
with accuracy of 0.01. In the paper the average results with
accuracyof0.1aregiven.TheinitialpHofartiﬁcialurinewas
adjustedtoavalueof5.8.Theabsorbancewasmeasuredwith
the spectrophotometer Ultrospec 2000 (Pharmacia Biotech)
at 630-nanometer wavelength.
Before the crystal growth experiment bacterial urease
activity and viability of bacteria in the presence of curcumin
were established. P. mirabilis suspension (5 × 105 CFU/mL)
was added to appropriate culture medium containing series
of curcumin dilution in wells of microtiter plates. To test
urease activity the compound was diluted in Christensen
medium with urea and a phenol red as a pH-indicator while
antimicrobial activity was determined in TSB. The curcumin
concentration tested was of the range 0.1 to 10mM, and its
biological activity was assessed after 24h incubation at 37◦C.
After incubation, curcumin concentration inhibiting activity
of urease (no change of Christensen medium color) was
determined. Additionally, bacterial growth in TSB testifying
the bacterial viability was observed.Evidence-Based Complementary and Alternative Medicine 3
3. Results andDiscussions
Before the crystal growth sets of experiments we have
examined concentrations of curcumin in the range from
0.1 to 10mM. The experiment performed with the use of
the method described in previous section has demonstrated
that none of the studied concentrations of curcumin acts
as bactericide. The performed experiments also show that
curcumin at a concentration lower than 1mM does not
inﬂuence the activity of urease. The concentration equal
to 1mM was the smallest one for which curcumin acts as
inhibitor in relation to urease activity. For concentration
higher than 1mM the inhibiting inﬂuence of curcumin on
activity of urease was still observed, however, more and more
greater problems with solubility of curcumin appeared as
described later in this section. The results of crystal growth
presented below were obtained for the concentration of
curcumin equal to 1mM.
The results of our crystal growth sets of experiments are
presented in Figure 2. The columns, left and right, present
the course of growth process of struvite crystals grown from
artiﬁcial urine in time, in the absence and in the presence of
curcumin, respectively.
First, let us analyse the growth process in the absence
of curcumin. In this case, ﬁrst single struvite crystals were
observed approximately at the third hour of the experiment,
for pH higher than 7.2 (Figure 2,p a n e lL 1 ) .W i t ht i m e
and with increase in pH the amount of crystals is greater
(Figure 2, panel L2). The most basic crystal morphology
is typical hemimorphic morphology of coﬃn-lid shape.
The hemimorphism and struvite morphology is analysed in
detail in [30]. The size of the largest crystals is about 55–
60μma l o n gb-axis. When pH increases further the habits
of single crystals remain the same, but the crystals very
frequently form twins. First of all the crystals show contact
twinning (Figure 2, panel L3), then contact twining turns
into penetration twinning (Figure 2, panel L3 and L4). For
the highest value of pH dendritic branches and dendrites
appear (Figure 2, panel L5). The highest value of pH equal
to 9.5 was achieved after 8h of incubation. The pH level is
correlated with the bacteria vitality, pH higher than 8 acts as
bactericide.TheevolutionofpHofurineintimeispresented
in Figure 3.
In the case of addition of curcumin our experiment
runs diﬀerently. First of all, the solubility of curcumin in
the solution of artiﬁcial urine is relatively low. Therefore,
we have initially observed unsolvable particles of curcumin
which then turn into “stellar” aggregates (Figure 2,p a n e lR 1 ,
R2, R3, and inset in panel R3). Besides, individual struvite
crystals appear later (Figure 2,p a n e lR 4 )c o m p a r e dw i t h
the absence of curcumin. Additionally, the size and number
of struvite crystals decrease with addition of curcumin
(Figure 2, panel R4). The largest crystals are of size 25μm
along b-axis. The majority of formed single crystals are
typical coﬃn-lid shape, the same as in the case of absence
of curcumin. Therefore, we conclude that curcumin does not
aﬀect the crystal morphology and habit. With time and with
further increase in pH very large X-shaped dendrites appear
(Figure 2, panel R5). From this it follows that the growth
process is strongly modiﬁed when curcumin is applied.
Figure 3 illustrates an example of pH proﬁle with and
without curcumin obtained at one of the set of experiments.
One may notice that this proﬁle is modiﬁed in the presence
of curcumin. In particular, in the presence of curcumin pH
of the urine increases much more slowly compared with
the absence of curcumin. The pH equal to 7.2, which is
required for struvite precipitation, is achieved after 4 hours
of incubation, while in the case of absence of curcumin
after 2.5 hours of incubation. Consequently, struvite crystals
appear much later in the presence of curcumin compared
with the absence of curcumin. Slower increase in pH value
may be caused by two reasons. Firstly, curcumin may act as
bactericide. Secondly, curcumin may inhibit the activity of
urease, not inﬂuencing the bacterium’s vitality. In our exper-
iment the second case arises: curcumin inhibits the activity
of urease. None of the examined concentrations of curcumin
acts as bactericide. As a consequence of inhibiting inﬂuence
of curcumin on urease activity, the pH value increases much
more slowly in the presence of curcumin. As the pH of
the solution is correlated with its supersaturation we may
conclude that curcumin preserves the urine undersaturated
with respect to struvite formation by inhibiting the activity
of urease. The urine is undersaturated for much longer time
compared with the absence of curcumin.
It is worth noting that the urease activity was estimated
using well-known and widely accepted method of direct
measurement of the change in pH [31–34].
Late appearance of struvite crystals in the presence
of curcumin compared with the control test (without
curcumin) may suggest also that the nucleation occurs later
in the presence of curcumin. In order to verify this idea,
we measured the turbidity of the artiﬁcial urine in the
presence and absence of curcumin during the experiments
in order to estimate the induction time, tin (time to induce
formation of detectable crystals), which characterizes the
nucleation process. The turbidity of a suspension with
bacteria is commonly measured as the absorbance of light
of a deﬁned wavelength [35, 36]. In our experiments the
absorbancewasmeasuredwithspectrophotometerUltrospec
2000 (Pharmacia Biotech) at 630-nanometer wavelength.
Figure 4 presents the absorbance-time graph in the case of
presence and absence of curcumin. This graph shows that in
the case of control test (without curcumin) the absorbance
initially reaches the values in the range 0.2-0.3 in absorbance
unit. These values of absorbance correspond to absorbance
of the solution of artiﬁcial urine with P. mirabilis bacteria of
the concentration approximately equal to 5×105 CFUmL
−1.
During the ﬁrst 3 hours of the experiment the concentration
of bacteria increases twice and then it stays constant up to
the end of the experiment. However, as the pH higher than 8
acts as bactericide the number of alive bacteria systematically
decreases. These changes in number of living bacteria have
no signiﬁcant inﬂuence on the absorbance values. On the
basis of Figure 4 one can see that the initially reached value
of absorbance then signiﬁcantly increases. We consider that
the appearance of crystals is detected when there is a sudden4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Struvite crystals grown from artiﬁcial urine infected with Proteus mirabilis in the absence (left column) and in the presence of
curcumin (right column). Scale bar in all pictures: 20μm.
increaseintheabsorbance.Thetimerelatedwiththissudden
increase is considered as induction time tin. In the case
presented in Figure 4, tin is equal to 1.5h. However, Figure 4
presents an exemplifying result which is representative for all
sets of experiments. In the sets of performed experiments the
inductiontimedoesnotexceed2hoursinthecaseofabsence
ofcurcumin.Suchavariationininductiontimeisadmissible
taking into account that the artiﬁcial urine with P. mirabilis
is a complex biological environment.
In the case of addition of curcumin it is found that the
absorbance initially has the highest value which decreases
until it reaches a constant value approximately equal to
0.4. Then, the absorbance increases with time. The ini-
tially high value of absorbance is correlated with weak
solubility of curcumin in artiﬁcial urine. As mentioned
above, just after addition of curcumin into solution of
artiﬁcial urine many unsolvable particles of curcumin were
observed. These unsolvable particles give initially high valueEvidence-Based Complementary and Alternative Medicine 5
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Figure 4: Absorbance of infected artiﬁcial urine versus time
without (control test) and with curcumin and absorbance of
noninfected urine with curcumin versus time.
of absorbance. With time these particles combine and form
“stellar” aggregates inducing the decrease of absorbance to a
constant value. In the case of noninfected urine this constant
value remains the same up to the end of the experiment
(Figure 4). However, in the case of infected urine, after
achieving this constant value, an increase in absorbance
occurs. This increase in absorbance after achieving this
constant value is related with the appearance of nuclei of
detectable size, that is, with induction time. It is clear that
the induction time with the presence of curcumin is much
longer compared with the control test (without curcumin).
Therefore, the nucleation in the presence of curcumin occurs
later compared with the control test. Moreover, Figure 4
shows that with addition of curcumin, lower absorbance
intensity is measured. This means that in the presence
of curcumin less detectable crystals are formed compared
with control test (without curcumin). Based on the classical
homogeneous nucleation theory [37], these results suggest
that the addition of curcumin shifts the Gibbs free energy
and critical nuclei radius to larger values. Larger critical
nuclei radius means that the system needs larger nuclei to
precipitate stable crystals, therefore the induction time is
longer. The longer induction time in the case of addition of
curcumin suggests also that the system needs higher energy
to overcome the barrier to precipitate crystals.
In our experiments both the homogeneous nucleation
and heterogeneous nucleation are possible. However, it
seems that the heterogeneous nucleation plays a key role
because this nucleation may be easily initiated on the
bacterial cells, which play the role of active sites. In the case
of the addition of curcumin there are unsolvable particles
of curcumin in the solution which may also serve as active
sites for heterogeneous nucleation. Therefore, in the case of
addition of curcumin there are much more places where the
heterogeneous nucleation may be initiated. It is known that
the increase in the number of such places is related to the
decrease in crystal size. Therefore, the crystals are smaller
compared with the crystals which grow in the case of absence
of curcumin in the same conditions. Additionally, with time
and with the increase of pH some of the small crystals form
aggregatesratherthangrowintolargecrystals.Consequently,
struvite crystals which grow with the presence of curcumin
are smaller and the number of crystals is less compared with
the absence of curcumin. These ﬁndings may suggest that,
at this stage, struvite crystals may be easily removed from
urinary tract with urine. However, with further increase in
pH very large X-shaped dendrites appear in the presence
of curcumin. We suggest that the formation of these large
dendrites may be associated with large number of 3D nuclei
and their aggregation in the presence of curcumin. These
largedendritesmayeasilyberetainedintheurinarytractand
consequently, at this stage, may stimulate the crystallization
process and stone formation.
The relative standard error (RSE) of the absorbance
measurements does not exceed 4% for control test. In the
case of infected urine with curcumin, for the ﬁrst stages of
experiment (up to approximately 2 hours of the experiment)
inallsetsofexperimentstheRSEofabsorbanceisonthelevel
of 10%. Afterward, beginning from 2 hours of experiments,
RSE is lower and does not exceed 5%. Similar situation is
in the case of noninfected urine with curcumin. From this
data it follows that the standard deviation and resulting from
it RSE is inﬂuenced mainly by curcumin. In particular, the
higher values of RSE at the ﬁrst stages of experiments testify
about the considerable inﬂuence of unsolvable particles of
curcumin on absorbance. With time the system attains an
equilibrium state and the RSE of absorbance is lower. All
these RSE values are admissible in this dynamic and complex
biological system. Independently on the RSE of absorbance
the induction times change in the range from 1.5 to 2 hours
in the case of control test and from 3.5 to 4 hours in the case
of infected urine with curcumin.
Weak solubility of curcumin is known and described in
the literature (e.g., [25]) and may be a limiting factor of its
therapeutic utility. Therefore, many attempts are currently
made to develop methods to improve its solubility.6 Evidence-Based Complementary and Alternative Medicine
4. Possible Mechanismof Urease
Inhibition by Curcumin
Ureases have been isolated from a wide variety of organisms
including plants, fungi, and bacteria. However, major
structural diﬀerences have been observed between the ure-
ases derived from plants and microorganisms. The urease
of Proteus mirabilis is a nickel-containing enzyme and
is composed of three subunit polypeptides [38]. More
exactly speaking, the urease active site is found to have
pseudooctahedral, paramagnetic, and binuclear nickel ions.
The urease-Ni ions play the key role in the mechanism
of urea degradation [39]. Urease inhibitors interact with
it and block its activity by inhibiting the urea hydrolysis
to ammonia and carbon dioxide. Urease inhibitors can be
divided into two major categories: (i) active-site directed
mode; (ii) mechanism-based directed mode. The active-
site directed inhibitors show close structural similarity with
urea—the enzyme’s substrate. Mechanism-based directed
inhibitors interfere with the enzyme’s catalysis mechanism
leading to its inhibition or inactivation [36].
In our opinion, curcumin appears to be mechanism-
based urease inhibitor. The chemical structure of curcumin
consists of two o-methoxy phenols attached symmetrically
through α,β-unsaturated β-diketone linker, which also
induces keto-enol tautomerism [25, 40], so it is a natural
polyphenol. It is possible that this compound inhibits urease
activity through a chelate interaction, which binds to the
urease active site; thereby curcumin makes a stable complex
with urease and in turn the inhibition of urease activity. The
diketone moiety of curcumin possesses chelating abilities
towards transition metals, to which nickel belongs also. The
chelation of curcumin towards transition metals such as iron
and copper has been found to be useful in the treatment of
Alzheimer’s disease [41].
The interaction between urease and curcumin may result
also from the electrostatic stabilization. Our results may
suggest that we deal with a form of mixed inhibition,
where the binding of the inhibitor to the urease active sites
reduces its activity but does not aﬀect the binding of urea.
We suppose such a mechanism because the extent of the
inhibition of curcumin depends strongly on its concen-
tration.
We consider our suggestions as stimulation of further
work to study the mechanism of urease inhibition by cur-
cumin. In order to establish the details of such a mecha-
nism, the structural changes occurring in urease upon its
interaction with curcumin should be examined. Under-
standing the mechanism of curcumin interaction with
urease of Proteus mirabilis should be the next step towards
the development of future therapeutic agents. The results
described in this study may be important preliminary step
to achieve the goal.
5. Conclusions
The results of our study demonstrate that curcumin inhibits
the activity of urease-bacterially produced enzyme, which is
driving force of struvite crystallization. Therefore, the pH
level of urine increases much more slowly in the presence
of curcumin compared with the absence of curcumin. For
this reason urine is undersaturated with respect to struvite
formation for longer time compared with the control test
(without curcumin). Increase in pH leads ﬁnally to crys-
tallization of struvite. The morphology of growing crystals
is the same as in the case of the absence of curcumin.
However, the crystals are smaller and the number of crystals
is less compared with the control test (without curcumin).
Therefore at this stage the crystals may be easily removed
from urinary tract with urine. With further increase in pH
very large X-shaped dendrites grow, larger than those in
the case of the absence of curcumin. Such large dendrites
may be retained in urinary tract and, in consequence, may
promote the formation of struvite. In conclusion, the results
demonstrate that curcumin has interesting and promising
properties, which combined with pharmacological safety,
render curcumin an attractive agent to explore further.
Acknowledgment
This work has been supported by the Polish Ministry of
ScienceandHigherEducation(MNiSzW),Grantno.NN202
033437.
References
[1] L. Benramdane, M. Bouatia, M. O. B. Idrissi, and M. Draoui,
“Infrared analysis of urinary stones, using a single reﬂection
accessory and a KBr pellet transmission,” Spectroscopy Letters,
vol. 41, no. 2, pp. 72–80, 2008.
[2] S. P. Lerner, M. J. Gleeson, and D. P. Griﬃth, “Infection
stones,” Journal of Urology, vol. 141, no. 3, pp. 753–758, 1989.
[3] G. Kramer, H. C. Klingler, and G. E. Steiner, “Role of bacteria
in the development of kidney stones,” Current Opinion in
Urology, vol. 10, no. 1, pp. 35–38, 2000.
[ 4 ]R .J .M c L e a n ,J .C .N i c k e l ,K .J .C h e n g ,a n dJ .W .C o s t e r t o n ,
“The ecology and pathogenicity of urease-producing bacteria
in the urinary tract,” Critical Reviews in Microbiology, vol. 16,
no. 1, pp. 37–79, 1988.
[5] K. H. Bichler, E. Eipper, K. Naber, V. Braun, R. Zimmermann,
and S. Lahme, “Urinary infection stones,” International Jour-
nal of Antimicrobial Agents, vol. 19, no. 6, pp. 488–498, 2002.
[6] B. Finlayson, “Calcium stones: some physical and clini-
cal aspects,” in Calcium Metabolism in Renal Failure and
Nephrolithiasis, David S. David, Ed., pp. 337–382, A Wiley
Medical Publication, New York, NY, USA, 1997.
[7] A. Wojewski and T. Zajaczkowski, “The treatment of bilateral
staghorn calculi of the kidneys,” International Urology and
Nephrology, vol. 5, no. 3, pp. 249–260, 1974.
[8] M. Singh, R. Chapman, G. C. Tresidder, and J. Blandy, “The
fate of the unoperated staghorn calculus,” British Journal of
Urology, vol. 45, no. 6, pp. 581–585, 1973.
[9] R. M. Feit and W. R. Fair, “The treatment of infection stones
with penicillin,” Journal of Urology, vol. 122, no. 5, pp. 592–
594, 1979.
[10] V. S. Joshi, B. B. Parekh, M. J. Joshi, and A. B. Vaidya, “Herbal
extracts of Tribulus terrestris and Bergenia ligulata inhibitEvidence-Based Complementary and Alternative Medicine 7
growth of calcium oxalate monohydrate crystals in vitro,”
Journal of Crystal Growth, vol. 275, no. 1-2, pp. e1403–e1408,
2005.
[11] C. K. Chauhan and M. J. Joshi, “Growth inhibition of Struvite
crystals in the presence of juice of Citrus medica Linn,”
Urological Research, vol. 36, no. 5, pp. 265–273, 2008.
[12] T. M. Kolev, E. A. Velcheva, B. A. Stamboliyska, and M.
Spiteller, “DFT and experimental studies of the structure
and vibrational spectra of curcumin,” International Journal of
Quantum Chemistry, vol. 102, no. 6, pp. 1069–1079, 2005.
[13] O. P. Sharma, “Antioxidant activity of curcumin and related
compounds,” Biochemical Pharmacology, vol. 25, no. 15, pp.
1811–1812, 1976.
[14] B. B. Aggarwal and K. B. Harikumar, “Potential therapeutic
eﬀects of curcumin, the anti-inﬂammatory agent, against
neurodegenerative, cardiovascular, pulmonary, metabolic,
autoimmune and neoplastic diseases,” International Journal of
Biochemistry and Cell Biology, vol. 41, no. 1, pp. 40–59, 2009.
[15] R. K. Maheshwari, A. K. Singh, J. Gaddipati, and R. C. Srimal,
“Multiple biological activities of curcumin: a short review,”
Life Sciences, vol. 78, no. 18, pp. 2081–2087, 2006.
[16] M. E. Egan, M. Pearson, S. A. Weiner et al., “Curcumin, a
major constituent of turmeric, corrects cystic ﬁbrosis defects,”
Science, vol. 304, no. 5670, pp. 600–602, 2004.
[17] K.Ozaki,Y.Kawata,S.Amano,andS.Hanazawa,“Stimulatory
eﬀect of curcumin on osteoclast apoptosis,” Biochemical
Pharmacology, vol. 59, no. 12, pp. 1577–1581, 2000.
[18] S. Pal, T. Choudhuri, S. Chattopadhyay et al., “Mechanisms
of curcumin-induced apoptosis of Ehrlich’s ascites carcinoma
cells,” Biochemical and Biophysical Research Communications,
vol. 288, no. 3, pp. 658–665, 2001.
[19] P. S. Negi, G. K. Jayaprakasha, L. Jagan Mohan Rao, and
K. K. Sakariah, “Antimicrobial activity of turmeric oil: a by-
product from curcumin manufacturer,” Agricultural and Food
Chemistry, vol. 47, pp. 4297–4300, 1999.
[20] G. K. Jayaprakasha, L. Jagan Mohan Rao, and K. K. Sakariah,
“Chemistry and biological activities of C. longa,” Trends in
Food Science and Technology, vol. 16, no. 12, pp. 533–548,
2005.
[ 2 1 ]D .A .D i c k i n s o n ,A .L .L e v o n e n ,D .R .M o e l l e r i n ge ta l . ,
“Human glutamate cysteine ligase gene regulation through
the electrophile response element,” Free Radical Biology and
Medicine, vol. 37, no. 8, pp. 1152–1159, 2004.
[22] B.B.Aggarwal,A.Kumar,andA.C.Bharti,“Anticancerpoten-
tial of curcumin: preclinical and clinical studies,” Anticancer
Research, vol. 23, no. 1A, pp. 363–398, 2003.
[23] E. Skrzypczak-Jankun, N. P. McCabe, S. H. Selman, and J.
Jankun, “Curcumin inhibits lipoxygenase by binding to its
central cavity: theoretical and X-ray evidence,” International
Journal of Molecular Medicine, vol. 6, no. 5, pp. 521–526, 2000.
[24] K. Ono, K. Hasegawa, H. Naiki, and M. Yamada, “Curcumin
has potent anti-amyloidogenic eﬀects for Alzheimer’s β-
amyloid ﬁbrils in vitro,” Journal of Neuroscience Research, vol.
75, no. 6, pp. 742–750, 2004.
[25] K. I. Priyadarsini, “Photophysics, photochemistry and pho-
tobiology of curcumin: studies from organic solutions, bio-
mimetics and living cells,” Journal of Photochemistry and
Photobiology C: Photochemistry Reviews, vol. 10, no. 2, pp. 81–
95, 2009.
[26] S. K. Dubey, A. K. Sharma, U. Narain, K. Misra, and U.
Pati,“Design,synthesisandcharacterizationofsomebioactive
conjugatesofcurcuminwithglycine,glutamicacid,valineand
demethylenated piperic acid and study of their antimicrobial
and antiproliferative properties,” European Journal of Medici-
nal Chemistry, vol. 43, no. 9, pp. 1837–1846, 2008.
[27] L. Shen and H. F. Ji, “Theoretical study on physicochemical
properties of curcumin,” Spectrochimica Acta—A, vol. 67, no.
3-4, pp. 619–623, 2007.
[28] J. Prywer and A. Torzewska, “Biomineralization of struvite
crystals by Proteus mirabilis from artiﬁcial urine and their
mesoscopic structure,” Crystal Research and Technology, vol.
45, no. 12, pp. 1283–1289, 2010.
[29] A. Torzewska, P. Sta ¸czek, and A. R´ o˙ zalski, “Crystallization
of urine mineral components may depend on the chemical
nature of Proteus endotoxin polysaccharides,” Journal of
Medical Microbiology, vol. 52, no. 6, pp. 471–477, 2003.
[30] J. Prywer and A. Torzewska, “Bacterially induced struvite
growth from synthetic urine: experimental and theoretical
characterization of crystal morphology,” Crystal Growth and
Design, vol. 9, no. 8, pp. 3538–3543, 2009.
[31] J. M. Bibby and D. W. L. Hukins, “Measurement of pH to
quantify urease activity,” Journal of Biochemical and Biophys-
ical Methods, vol. 25, no. 4, pp. 231–236, 1992.
[32] C.Athmann,N.Zeng,T.Kangetal.,“SitesofpHelevationdue
to NH3 generation bytheintra-bacterial ureaseof Helicobacter
pylori co-cultured with gastric cells,” The Journal of Clinical
Investigation, vol. 106, pp. 339–347, 2000.
[33] B. Krajewska, “Ureases I. functional, catalytic and kinetic
properties: a review,” Journal of Molecular Catalysis B: Enzy-
matic, vol. 59, no. 1–3, pp. 9–21, 2009.
[34] H. L. T. Mobley, M. D. Island, and R. P. Hausinger, “Molecular
biology of microbial ureases,” Microbiological Reviews, vol. 59,
no. 3, pp. 451–480, 1995.
[35] A. L. Koch, “Growth measurement,” in Methods for General
andMolecularBacteriology,P .Gerhar dt,R.G.E.M urra y ,W .A.
Wood, and N. R. Krieg, Eds., pp. 248–277, American Society
for Microbiology, Washington, DC, USA, 1994.
[36] R. Lindqvist, “Estimation of Staphylococcus aureus growth
parameters from turbidity data: characterization of strain
variation and comparison of methods,” Applied and Environ-
mental Microbiology, vol. 72, no. 7, pp. 4862–4870, 2006.
[37] K. Sangwal, Additives and Crystallization Processes: From
Fundamentals to Applications,W i l e y ,N e w Y o r k ,N Y ,U S A ,
2007.
[38] B. D. Jones and H. L. T. Mobley, “Proteus mirabilis urease:
nucleotide sequence determination and comparison with jack
bean urease,” Journal of Bacteriology, vol. 171, no. 12, pp.
6414–6422, 1989.
[39] Z. Amtul, A. Atta-ur-Rahman, R. A. Siddiqui, and M. I.
Choudhary, “Chemistry and mechanism of urease inhibition,”
Current Medicinal Chemistry, vol. 9, no. 14, pp. 1323–1348,
2002.
[ 4 0 ] F .P a y t o n ,P .S a n d u s k y ,a n dW .L .A l w o r t h ,“ N M Rs t u d yo ft h e
solution structure of curcumin,” Journal of Natural Products,
vol. 70, no. 2, pp. 143–146, 2007.
[41] S. Adhikari, K. I. Priyadarsini, and T. Mukherjee, “Physico-
chemical studies on the evaluation of the antioxidant activity
of herbal extracts andactive principles of someIndian medici-
nal plants,” Journal of Clinical Biochemistry and Nutrition, vol.
40, no. 3, pp. 174–183, 2007.